Literature DB >> 28516750

Quality of Life of SGA Children with Short Stature Receiving GH Treatment in Japan.

Ryo Takahashi1, Madoka Ogawa2, Hisao Osada3.   

Abstract

The objective of this study was to compare the quality of life (QOL) of small for gestational age (SGA) children with short stature with that of children with normal height, and examine the effects of growth hormone (GH) treatment on the QOL of the SGA children using questionnaires administered to their parents or guardians. The results showed that QOL in daily living of SGA children with short stature was lower than that of normal children based on the perceptions of their parents or guardians. In addition, GH treatment improved the physical domain of QOL of SGA children with short stature. This study suggests that GH treatment can improve QOL and reduce psychosocial problems related to short stature. Copyright© of YS Medical Media ltd.

Entities:  

Keywords:  Growth hormone treatment; Psychosocial problems; Quality of life; SGA children with short stature

Mesh:

Substances:

Year:  2017        PMID: 28516750     DOI: 10.17458/per.vol14.2017.too.qualityoflife

Source DB:  PubMed          Journal:  Pediatr Endocrinol Rev        ISSN: 1565-4753


  3 in total

Review 1.  The Rationale for Growth Hormone Therapy in Children with Short Stature.

Authors:  Annalisa Deodati; Stefano Cianfarani
Journal:  J Clin Res Pediatr Endocrinol       Date:  2017-12-27

2.  Effectiveness of a smartphone application on medication adherence in children with short stature receiving GH therapy: A multicenter prospective cohort study (GTL-App).

Authors:  Tatsuhiko Urakami
Journal:  Clin Pediatr Endocrinol       Date:  2021-04-03

3.  Assessing health-related quality of life in Japanese children with a chronic condition: validation of the DISABKIDS chronic generic module.

Authors:  Hatoko Sasaki; Naoko Kakee; Naho Morisaki; Rintaro Mori; Ulrike Ravens-Sieberer; Monika Bullinger
Journal:  Health Qual Life Outcomes       Date:  2018-05-02       Impact factor: 3.186

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.